Genes
Oligo Pools
NGS
Variant Libraries
Synthetic Controls
Antibody Discovery
IVDR Solutions
Webinar
Twist Bioscience HQ
681 Gateway Blvd
South San Francisco, CA 94080
HT-SPR Technology to Inform and Accelerate the Antibody Discovery Process
HT-SPR Technology to Inform and Accelerate the Antibody Discovery Process
Presented by
Daniel Bedinger
Application Science Team Lead, Carterra
RECORDED AT Writing the Future of Drug Discovery
Covered in this Webinar
How NGS and synthetic DNA strategies are bringing the timelines to Ab candidate selection to weeks rather than months or years
How common solutions such as HT-SPR can be implemented to eliminate bottlenecks
The role of HT-SPR and its successful enablement of discovery efforts against emerging public health threats such as COVID-19
Biotherapeutic candidate discovery and development has been led by a diverse set of strategies used to identify antibody candidates. In addition to traditional hybridoma and phage approaches, NGS and synthetic DNA strategies are bringing the timelines to candidate selection to weeks rather than months or years. Despite these varied workflows, common solutions such as HT-SPR can be implemented to eliminate bottlenecks. In this talk the role of HT-SPR and its successful enablement of discovery efforts against emerging public health threats such as COVID-19 will be explored as a technology in biotherapeutics discovery that is deployable in any workflow.
Share your details to Watch the Webinar
